Nasdaq Accepts NLS Pharmaceutics’ Plan to Regain Listing Compliance
ZURICH, SWITZERLAND / ACCESSWIRE / March 11, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage...
Year: 2024
Scryb Appoints Yoav Raiter, CEO, to its Board of Directors
Toronto, Ontario--(Newsfile Corp. - March 10, 2024) - Scryb Inc. (CSE: SCYB) (OTC Pink: SCYRF) (FSE: EIY) ("Scryb'' or the...
New Research Reveals Genomic Profile of Seborrheic Dermatitis and Answers Key Questions on Immune Response and Skin Barrier Dysfunction
Findings show that seborrheic dermatitis is a unique inflammatory skin disease with its own molecular signatureSuggests skin barrier disruption in...
Alumis Presents Positive Data from Phase 2 Clinical Trial of ESK-001, an Oral Allosteric TYK2 Inhibitor for the Treatment of Plaque Psoriasis, at AAD Annual Meeting
– STRIDE Phase 2 primary endpoint of PASI 75 and key secondary endpoints met at all clinically relevant doses tested;...
Samsung Bioepis Presents Two Abstracts for Its Immunology Portfolio at the 2024 American Academy of Dermatology (AAD) Annual Meeting
Interchangeability study for HADLIMA (adalimumab-bwwd) was conducted in accordance with the FDA’s Guidance for Industry; primary pharmacokinetics (PK) endpoints as...
Ultimovacs ASA: Mandatory notification of trades by primary insider
Oslo, 9 March 2024: Langøya Invest AS, a closely related party of Ketil Fjerdingen, a board member and primary insider...
Aesthetic Medical International Holdings Group Ltd. Announces Receipt of a Letter of Expected Delisting Determination From Nasdaq Staff and Intention to Request a Hearing before the Nasdaq Hearings Panel
SHENZHEN, China, March 08, 2024 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”),...
Confluent Appoints Sandy Stojkovski and Brian Yoor to its Board of Directors
SCOTTSDALE, Ariz., March 08, 2024 (GLOBE NEWSWIRE) -- Confluent Medical Technologies, a leading materials science platform that supports the design,...
Ultimovacs ASA: Mandatory notification of trades by primary insider
Oslo, 8 March 2024: CGS Holding AS, a closely related party of Leiv Askvig, a board member and primary insider...
Sonendo Announces Departure of Chief Financial Officer
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (OTCQX: SONX) (“Sonendo”), a leading dental technology company and developer of the GentleWave® System, today...
Psyched Wellness Provides Corporate Update
Toronto, Ontario--(Newsfile Corp. - March 8, 2024) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or...
Ainos Reports Full Year 2023 Financial Results
Strategic pivot towards VELDONA and AI-powered point-of-care testing to continue in 2024Advancing VELDONA drug candidates to Phase III clinical studiesExpanding...
Avenues Recovery Centers in Louisiana Designated as Blue Distinction(R) Centers
Avenues Recovery Center's Two Louisiana Facilities Designated as Blue Distinction® Centers for Substance Use Treatment and RecoveryNEW ORLEANS, LA /...
Sinceri Senior Living Welcomes New Community in Virginia
VANCOUVER, WA / ACCESSWIRE / March 8, 2024 / Sinceri Senior Living, a senior living management company, is pleased to...
What is GRC in Healthcare?
By Charlie Falcone, CEO at Verisys Charlie Falcone Governance, Risk Management, and Compliance (GRC) in healthcare is an integrated approach...
Embarking on a Transformative Journey: Oxygen Announces Temporary Closure of Banking Services to Focus on Health Solutions
PRINCETON, NJ / ACCESSWIRE / March 8, 2024 / Oxygen, a banking platform dedicated to serving the extraordinary, today announces...
Scientific Industries Announces Industry Veteran, John Nicols, as New Board Member and Chairman of Scientific Bioprocessing Inc.
BOHEMIA, NY / ACCESSWIRE / March 8, 2024 / Scientific Industries, Inc. ("SI") (OTCQB:SCND) announced the appointment of John Nicols...
Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term,...
United States Medical Diagnostics Research Report 2024: Market Impacts of Surging Adoption of Healthcare Wearables and Rising Integration with Artificial Intelligence – Forecasts to 2028 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "US Medical Diagnostics Market (Product Type, End-User & Region): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)"...
Red Light Holland Commences Experimental Research on Psilocybin Truffles to Develop Process for Commercial Manufacturing of Natural-Source Active Pharmaceutical Ingredient
Toronto, Ontario--(Newsfile Corp. - March 8, 2024) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light...